Artículos de revistas
Detection of hepatitis C virus resistant mutants in the era of direct acting antivirals
Fecha
2014-01-01Registro en:
American Journal of Infectious Diseases, v. 10, n. 4, p. 182-186, 2014.
1553-6203
10.3844/ajidsp.2014.182.186
2-s2.0-84920986572
Autor
Universidade Estadual Paulista (UNESP)
Institución
Resumen
Hepatitis C Virus (HCV) infects millions of people and represents an important public health problem in different regions of the world. Drug resistance is a major challenge for HCV-infection related control. Importantly, the arrival of a plethora of novel, more powerful drugs has revolutionized the field of HCV treatment. Here, we discuss the relevance of identification of HCV resistant mutants from a clinical standpoint. The advantage and limitations of molecular testing in clinical setting is presented.